Liquid biopsy company Angle recently secured its first large-scale pharma services contract. Clinical Trials Arena caught up with the firm’s head of clinical laboratories Madeline Repollet to find out how its blood test works and...
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been...
Covid-19 long-hauler treatment trials will likely rely on established endpoints and trial design features used...
The drug development industry has seen a major shift of clinical activity away from large...
According to Frost & Sullivan, the CRO market is forecast to grow to US$ 71.7billion...
The number of biotech-sponsored clinical trials in Australia has grown by more than +10% on average each year between 2017 and 2019 and generally, Australia is well regarded as a…
Asia-Pacific biotech specialist CRO Novotech has released a new webinar about the advantages of conducting oncology clinical trials in the Asia-Pacific. The panel included leading key opinion leaders from Australia…
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of all ongoing and planned hepatology trials globally. Liver diseases are…
The leading Asia-Pacific biotech specialist CRO Novotech is releasing a series of webinars about the advantages of conducting clinical trials in the Asia-Pacific. Sites across the APAC region have quickly…
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment and vaccine candidates. The South Korean Ministry of Food and…
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the global COVID-19 crisis. According to their data, the top 10…
© Copyright Verdict Media Limited 2021
